Bayer expands fight against cancer

Bayer received European Union approval to market the drug Nexavar for different types of thyroid cancer. In a statement, the company explained that the oral treatment, also known as Sorafenib, can be done by patients with differentiated thyroid cancer, is located or in the process of metastasis, that doesn't respond to treatment with radioactive iodine. The medicine is used also in combating kidney cancer or liver.